Custom strain development and fermentation process optimization for industrial production of enzymes, biochemicals, and recombinant proteins.
Gram-positive industrial chassis with robust growth, efficient secretion capacity, and well-characterized genetics. Ideal for industrial production of high-value compounds.
We integrate strain engineering, pathway design, and fermentation development to deliver tailored production strains ready for scale-up.
Starting from a wild-type or defined host, we apply rational and combinatorial strategies to redirect metabolic fluxes toward the target compound.
We design and evaluate fermentation parameters—medium composition, pH, temperature, feeding strategy—to evaluate productivity and stability.
Selection or construction of promoters, ribosome binding sites, and gene deletion/insertion cassettes tailored to the target pathway.
HPLC, LC-MS, and appropriate activity assays assess the product; genetic sequencing verifies the engineered construct.
Dedicated scientific lead to align milestones with your timeline; flexible scope adjustments as data emerge.
All deliverables are documented to support regulatory filing, publication, or internal downstream processing.
Projects are defined case-by-case during consultation. The table below lists typical parameters that can be tailored to your specific needs.
| Parameter | Typical project scope |
|---|---|
| Host strain | Wild-type or defined B. subtilis strain (e.g., 168, WB800, or proprietary isolate as provided) |
| Target molecule | Enzymes, proteins, organic acids, amino acids, biopolymers, or other metabolites |
| Pathway genes | Provided by customer or sourced from public/available libraries (subject to licensing) |
| Genetic modifications | Gene deletions, insertions, promoter replacements, and expression cassette integration |
| Screening method | Selectable markers, fluorescence-based, or product-specific assays; throughput scoped per project |
| Fermentation scale | Scoped per project after consultation |
| QC & analytics | HPLC, LC-MS, enzymatic activity, cell density, genetic stability; additional assays scoped per project |
Our streamlined process moves from consultation to engineered strain and process handoff in five defined stages.
We review your target molecule, production goals, and constraints. Together we select host strain, define acceptance criteria, and establish milestones.
Using bioinformatics and synthetic biology tools, we design the metabolic pathway and build genetic constructs for transformation into Bacillus subtilis.
We transform constructs, screen colonies, and iteratively refine gene expression or deletion to evaluate titer, yield, and byproduct profile.
Shake-flask and bioreactor runs identify optimal medium, pH, temperature, and feeding regimes. Process parameters are documented for scale-up.
The engineered strain and fermentation process are QC-checked. Deliverables include the strain, process SOP, analytical reports, and a final project summary.
This service supports a broad range of industrial biotechnology applications, from enzyme production to biochemical synthesis.
Engineer B. subtilis for high-yield secretion of proteases, amylases, lipases, cellulases, and other industrial enzymes used in detergents, food processing, and biofuel production.
Evaluate carbon flux toward organic acids, amino acids, vitamins, and biopolymers (e.g., poly-γ-glutamic acid, riboflavin) for food, feed, and pharmaceutical applications.
Produce therapeutic and diagnostic proteins, vaccine antigens, and protein-based biomaterials in host strains selected for the intended use, with low endotoxin background; food-use safety status must be assessed for the strain, product, and intended use.
Common questions about project scope, timeline, and deliverables.
We routinely perform gene deletions, insertions, and promoter replacements using homologous recombination and CRISPR-based tools. Multi-gene pathway integration and marker removal are included when scoped. Each modification is sequence-verified and characterized for growth and productivity.
Engineered strains are passaged under non-selective conditions to evaluate genetic stability. Plasmid retention, gene copy number, and product titer are monitored over serial subcultures. Stability data are provided as part of the final QC report.
Yes. We can integrate customer-provided genes, promoters, or pathway cassettes into the B. subtilis chassis. Please discuss any licensing or confidentiality requirements during the project definition stage.
Standard scope includes shake-flask screening and lab bioreactor (scale scoped per project) optimization. Scale-up to pilot (scale scoped per project) or larger is available as a separate scope item. Process parameters are documented to support further scale-up.
Get a customized quote for your Bacillus subtilis Metabolic Engineering project. Our experts will respond within 24 hours.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.